369 related articles for article (PubMed ID: 30515788)
1. RUNX1-dependent mechanisms in biological control and dysregulation in cancer.
Hong D; Fritz AJ; Gordon JA; Tye CE; Boyd JR; Tracy KM; Frietze SE; Carr FE; Nickerson JA; Van Wijnen AJ; Imbalzano AN; Zaidi SK; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2019 Jun; 234(6):8597-8609. PubMed ID: 30515788
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor.
Hong D; Fritz AJ; Finstad KH; Fitzgerald MP; Weinheimer A; Viens AL; Ramsey J; Stein JL; Lian JB; Stein GS
Mol Cancer Res; 2018 Dec; 16(12):1952-1964. PubMed ID: 30082484
[TBL] [Abstract][Full Text] [Related]
3. Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition.
Hong D; Messier TL; Tye CE; Dobson JR; Fritz AJ; Sikora KR; Browne G; Stein JL; Lian JB; Stein GS
Oncotarget; 2017 Mar; 8(11):17610-17627. PubMed ID: 28407681
[TBL] [Abstract][Full Text] [Related]
4. A role for RUNX1 in hematopoiesis and myeloid leukemia.
Ichikawa M; Yoshimi A; Nakagawa M; Nishimoto N; Watanabe-Okochi N; Kurokawa M
Int J Hematol; 2013 Jun; 97(6):726-34. PubMed ID: 23613270
[TBL] [Abstract][Full Text] [Related]
5. RUNX1 as a Novel Molecular Target for Breast Cancer.
Ariffin NS
Clin Breast Cancer; 2022 Aug; 22(6):499-506. PubMed ID: 35599145
[TBL] [Abstract][Full Text] [Related]
6. Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasion.
Browne G; Taipaleenmäki H; Bishop NM; Madasu SC; Shaw LM; van Wijnen AJ; Stein JL; Stein GS; Lian JB
J Cell Physiol; 2015 Oct; 230(10):2522-32. PubMed ID: 25802202
[TBL] [Abstract][Full Text] [Related]
7. New insights into the role of Runx1 in epithelial stem cell biology and pathology.
Scheitz CJ; Tumbar T
J Cell Biochem; 2013 May; 114(5):985-93. PubMed ID: 23150456
[TBL] [Abstract][Full Text] [Related]
8. Runx transcription factors in the development and function of the definitive hematopoietic system.
de Bruijn M; Dzierzak E
Blood; 2017 Apr; 129(15):2061-2069. PubMed ID: 28179276
[TBL] [Abstract][Full Text] [Related]
9. RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.
van Bragt MP; Hu X; Xie Y; Li Z
Elife; 2014 Nov; 3():e03881. PubMed ID: 25415051
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 and cancer.
Lin TC
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188715. PubMed ID: 35271994
[TBL] [Abstract][Full Text] [Related]
11. The enigmatic role of RUNX1 in female-related cancers - current knowledge & future perspectives.
Riggio AI; Blyth K
FEBS J; 2017 Aug; 284(15):2345-2362. PubMed ID: 28304148
[TBL] [Abstract][Full Text] [Related]
12. RUNX transcription factors at the interface of stem cells and cancer.
Deltcheva E; Nimmo R
Biochem J; 2017 May; 474(11):1755-1768. PubMed ID: 28490659
[TBL] [Abstract][Full Text] [Related]
13. RUNX1 and its understudied role in breast cancer.
Janes KA
Cell Cycle; 2011 Oct; 10(20):3461-5. PubMed ID: 22024923
[TBL] [Abstract][Full Text] [Related]
14. Gatekeeper function of the RUNX1 transcription factor in acute leukemia.
Niebuhr B; Fischer M; Täger M; Cammenga J; Stocking C
Blood Cells Mol Dis; 2008; 40(2):211-8. PubMed ID: 17920312
[TBL] [Abstract][Full Text] [Related]
15. RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes.
Recouvreux MS; Grasso EN; Echeverria PC; Rocha-Viegas L; Castilla LH; Schere-Levy C; Tocci JM; Kordon EC; Rubinstein N
Oncotarget; 2016 Feb; 7(6):6552-65. PubMed ID: 26735887
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
Chen K; Pan G
Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
[TBL] [Abstract][Full Text] [Related]
17. Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer.
Farina NH; Scalia S; Adams CE; Hong D; Fritz AJ; Messier TL; Balatti V; Veneziano D; Lian JB; Croce CM; Stein GS; Stein JL
J Cell Physiol; 2020 Jun; 235(6):5318-5327. PubMed ID: 31919859
[TBL] [Abstract][Full Text] [Related]
18. The Role of RUNX1 in NF1-Related Tumors and Blood Disorders.
Na Y; Huang G; Wu J
Mol Cells; 2020 Feb; 43(2):153-159. PubMed ID: 31940719
[TBL] [Abstract][Full Text] [Related]
19. Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.
Scheitz CJ; Lee TS; McDermitt DJ; Tumbar T
EMBO J; 2012 Nov; 31(21):4124-39. PubMed ID: 23034403
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.
Browne G; Dragon JA; Hong D; Messier TL; Gordon JA; Farina NH; Boyd JR; VanOudenhove JJ; Perez AW; Zaidi SK; Stein JL; Stein GS; Lian JB
Tumour Biol; 2016 Jul; 37(7):8825-39. PubMed ID: 26749280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
